Synthesis of N1′-([18F]fluoroethyl)naltrindole ([18F]FEtNTI): a radioligand for positron emission tomographic studies of delta opioid receptors

N1′‐([18F]fluoroethyl)naltrindole ([18F]FEtNTI), a novel analog of the delta opioid receptor antagonist naltrindole (NTI), has been prepared for evaluation as a radioligand for use in positron emission tomography. The precursor for radiolabeling was obtained in four steps from naltrexone hydrochlori...

Full description

Saved in:
Bibliographic Details
Published inJournal of labelled compounds & radiopharmaceuticals Vol. 42; no. 1; pp. 43 - 54
Main Authors Mathews, William B., Kinter, Chris M., Palma, James, Daniels, Robert V., Ravert, Hayden T., Dannals, Robert F., Lever, John R.
Format Journal Article
LanguageEnglish
Published Chichester, UK John Wiley & Sons, Ltd 01.01.1999
Wiley
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:N1′‐([18F]fluoroethyl)naltrindole ([18F]FEtNTI), a novel analog of the delta opioid receptor antagonist naltrindole (NTI), has been prepared for evaluation as a radioligand for use in positron emission tomography. The precursor for radiolabeling was obtained in four steps from naltrexone hydrochloride with an overall yield of 47%. Nucleophilic displacement of a tosylate leaving group by [18F]fluoride, followed by hydrogenolysis (H2, 10% Pd/C) of a benzyl protecting group on the phenolic moiety, gave [18F]FEtNTI. The average (n=5) time for radiosynthesis, HPLC purification, and formulation was 77 min from end of bombardment. [18F]FEtNTI of high radiochemical purity was obtained with an average specific activity of 846 mCi/μmol at end of synthesis, and an average radiochemical yield of 10% (not corrected for decay). Copyright © 1999 John Wiley & Sons, Ltd.
Bibliography:istex:63678F9F019CBC70361E355054DCC42FFB8190E6
ark:/67375/WNG-B9N5NDHX-K
ArticleID:JLCR165
ISSN:0362-4803
1099-1344
DOI:10.1002/(SICI)1099-1344(199901)42:1<43::AID-JLCR165>3.0.CO;2-2